Hydrazonophenol, a Food Vacuole-Targeted and Ferriprotoporphyrin IX-Interacting Chemotype Prevents Drug-Resistant Malaria.
Shubhra Jyoti SahaAsim Azhar SiddiquiSaikat PramanikDebanjan SahaRudranil DeSomnath MazumderSubhashis DebsharmaShiladitya NagChinmoy BanerjeeUday BandyopadhyayPublished in: ACS infectious diseases (2018)
The rapid emergence of resistance against frontline antimalarial drugs essentially warrants the identification of new-generation antimalarials. Here, we describe the synthesis of ( E)-2-isopropyl-5-methyl-4-((2-(pyridin-4-yl)hydrazono)methyl)phenol (18), which binds ferriprotoporphyrin-IX (FeIII-PPIX) ( Kd = 33 nM) and offers antimalarial activity against chloroquine-resistant and sensitive strains of Plasmodium falciparum in vitro. Structure-function analysis reveals that compound 18 binds FeIII-PPIX through the -C═N-NH- moiety and 2-pyridyl substitution at the hydrazine counterpart plays a critical role in antimalarial efficacy. Live cell confocal imaging using a fluorophore-tagged compound confirms its accumulation inside the acidic food vacuole (FV) of P. falciparum. Furthermore, this compound concentration-dependently elevates the pH in FV, implicating a plausible interference with FeIII-PPIX crystallization (hemozoin formation) by a dual function: increasing the pH and binding free FeIII-PPIX. Different off-target bioassays reduce the possibility of the promiscuous nature of compound 18. Compound 18 also exhibits potent in vivo antimalarial activity against chloroquine-resistant P. yoelii and P. berghei ANKA (causing cerebral malaria) in mice with negligible toxicity.
Keyphrases
- plasmodium falciparum
- drug resistant
- multidrug resistant
- acinetobacter baumannii
- escherichia coli
- high resolution
- fluorescent probe
- oxidative stress
- type diabetes
- subarachnoid hemorrhage
- metabolic syndrome
- human health
- dna binding
- optical coherence tomography
- mass spectrometry
- cystic fibrosis
- adipose tissue
- anti inflammatory
- climate change
- quantum dots
- transcription factor
- drug induced
- oxide nanoparticles